0B68 Mastrangelo, Michael J. - Thomas Jefferson University - Thomas Jefferson University
Dr. Mastrangelo

Michael J. Mastrangelo, MD

Contact Dr. Mastrangelo

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Expression of insulin-like growth factor-1 receptor in metastatic uveal melanoma and implications for potential autocrine and paracrine tumor cell growth
  2. A pilot study of sunitinib malate in patients with metastatic uveal melanoma
  3. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
  4. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma
  5. Masthead
  6. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  7. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
  8. In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2
  9. Conjunctival melanoma: Bladder and upper urinary tract metastases
  10. The wrath of RAFs: Rogue behavior of B-RAF kinase inhibitors
  11. Malignant melanoma presenting as obstructive jaundice secondary to metastasis to the ampulla of vater
  12. The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?
  13. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  14. High-dose immunoembolization: Survival benefit in patients with hepatic metastases from uveal melanoma
  15. Impact of malignant disease on young adults.
  16. Foreword
  17. Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colo 0575 ny-stimulating factor
  18. Malignant melanoma of the gallbladder: A report of two cases and review of the literature
  19. In Appreciation: John Williamson Yarbro, MD, PhD
  20. Reflecting on the 2001 American Joint Committee on Cancer Staging System for Melanoma